Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04909619 · ClinicalTrials.gov registry record · NA

Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes

A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT04909619: Completed NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT04909619 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04909619, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Increased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise. The goal is to improve all outcomes by identifying the most effective evidenced-based method of intra-operative pain control.

Primary Outcome

The primary outcome for this aim will be pain scores, as determined by the Face, Legs, Activity, Crying, and Consolability scale. Minimum value is 0, maximum value is 10. Higher scores indicate more pain and therefore a worse outcome.

Interventions

  • PROCEDURE Ultrasound-guided bilateral suprazygomatic maxillary nerve block
  • PROCEDURE Local anesthetic infiltration of the palate

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-03-01
Est. Completion 2025-06-30
Phase NA

What the finished NCT04909619 record still lists

NCT04909619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Ultrasound-guided bilateral suprazygomatic maxillary nerve block is the first listed.

NCT04909619 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04909619 about?

NCT04909619 is a clinical study titled "Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes". Increased pain after cleft palate surgery is the leading cause of increased hospital length of stay, delayed oral intake, readmission, and respiratory compromise. The goal is to improve all outcomes by identifying the most effective evidenced-based method of intra-operative pain control.

What is the current status of trial NCT04909619?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-03-01. Estimated completion is 2025-06-30.

What interventions are being tested in trial NCT04909619?

The interventions under investigation include: Ultrasound-guided bilateral suprazygomatic maxillary nerve block (PROCEDURE), Local anesthetic infiltration of the palate (PROCEDURE).

Who is sponsoring clinical trial NCT04909619?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04909619's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04909619, the US trial registry maintained by the National Library of Medicine. NCT04909619 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.